Good evening :)
Place Order
Add to Watchlist

F D C Ltd

FDC

F D C Ltd

FDC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹8,696 cr, stock is ranked 587
Moderate RiskStock is 2.43x as volatile as Nifty
564.905.76% (+30.75)
564.905.76% (+30.75)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹8,696 cr, stock is ranked 587
Moderate RiskStock is 2.43x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹8,696 cr, stock is ranked 587
Moderate RiskStock is 2.43x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
27.664.15
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
52.446.700.47%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

FDC Limited is a pharmaceutical company engaged in manufacture of specialized formulations, and oral rehydration salts (ORS). Its brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 12.51%, vs industry avg of 9.03%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.52% to 0.54%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 12.44%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue1,032.861,064.151,126.031,134.171,413.091,430.241,604.011,833.612,044.572,145.48
Raw Materialssubtract363.25340.29354.77367.29420.53440.17595.64670.93709.631,681.68
Power & Fuel Costsubtract23.1421.5522.0024.6127.4027.0828.9234.1237.38
Employee Costsubtract175.76191.08216.67225.57277.48296.29343.33390.90413.40
Selling & Administrative Expensessubtract108.33117.71137.51138.37160.43156.64234.10289.12312.99
Operating & Other expensessubtract95.11105.66117.91107.01166.4181.1072.24147.71131.01
Depreciation/Amortizationsubtract33.7334.6235.1433.2437.4637.8137.3038.9439.9241.30
Interest & Other Itemssubtract1.401.411.401.443.423.433.094.094.034.28
Taxes & Other Itemssubtract63.4763.3067.1266.8480.0786.3772.9963.7691.00103.84
EPS9.3210.429.689.5613.7717.7412.8211.5918.5719.31
DPS2.252.250.000.000.800.000.000.000.00
Payout ratio0.240.220.000.000.060.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2016

Annual Report Unavailable

Investor Presentation

May 26PDF
FY 2017

Annual Report Unavailable

Investor Presentation

Jun 6PDF
Nov 11PDF
FY 2018

Annual Report Unavailable

FY 2019

Annual Report Unavailable

FY 2022

Annual report

PDF

Investor Presentation

May 26PDF
FY 2023

Annual report

PDF

Investor Presentation

Feb 9PDF
Nov 14PDF
Aug 4PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
F D C Ltd28.494.15
Sun Pharmaceutical Industries Ltd47.856.830.71%
Cipla Ltd31.324.820.81%
Torrent Pharmaceuticals Ltd71.3117.230.80%

Price Comparison

Compare FDC with any stock or ETF
Compare FDC with any stock or ETF
FDC
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding69.66%6.51%0.22%2.51%21.10%

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Shareholding History

MarJunSepDec '23MarJun3.80%2.06%2.42%2.43%2.65%2.51%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding F D C Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Nippon India Small Cap Fund - Growth - Direct Plan

Growth
2.5780%0.37%0.02%91/238 (-14)
ICICI Prudential Smallcap Fund - Growth - Direct Plan

Growth
0.8238%0.81%-0.22%29/117 (+2)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Plan Growth

Growth
0.7402%1.30%-0.38%23/48 (-5)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateMar 19, 2020

Interim
Interim | Div/Share: ₹0.80

Dividend/Share

0.80

Ex DateEx Date

Mar 19, 2020

Cash Dividend

Ex DateEx DateAug 8, 2017

Final
Final | Div/Share: ₹2.25

Dividend/Share

2.25

Ex DateEx Date

Aug 8, 2017

Cash Dividend

Ex DateEx DateMar 17, 2016

Interim
Interim | Div/Share: ₹2.25

Dividend/Share

2.25

Ex DateEx Date

Mar 17, 2016

Cash Dividend

Ex DateEx DateSep 23, 2015

Final
Final | Div/Share: ₹2.25

Dividend/Share

2.25

Ex DateEx Date

Sep 23, 2015

Cash Dividend

Ex DateEx DateJul 28, 2014

Final
Final | Div/Share: ₹2.25

Dividend/Share

2.25

Ex DateEx Date

Jul 28, 2014

News & Opinions
Spotlight
FDC Ltd leads gainers in 'A' group

Kaynes Technology India Ltd, Engineers India Ltd, Mrs Bectors Food Specialities Ltd and Varun Beverages Ltd are among the other gainers in the BSE's 'A' group today, 12 September 2024.FDC Ltd soared 10.82% to Rs 639.75 at 11:45 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 3.63 lakh shares were traded on the counter so far as against the average daily volumes of 30294 shares in the past one month. Kaynes Technology India Ltd spiked 6.79% to Rs 4976.3. The stock was the second biggest gainer in 'A' group. On the BSE, 18895 shares were traded on the counter so far as against the average daily volumes of 18212 shares in the past one month. Engineers India Ltd surged 5.87% to Rs 221.9. The stock was the third biggest gainer in 'A' group. On the BSE, 5.36 lakh shares were traded on the counter so far as against the average daily volumes of 3.5 lakh shares in the past one month. Mrs Bectors Food Specialities Ltd spurt 5.36% to Rs 1920. The stock was the fourth biggest gainer in 'A' group. On the BSE, 47524 shares were traded on the counter so far as against the average daily volumes of 18204 shares in the past one month. Varun Beverages Ltd exploded 5.14% to Rs 659.85. The stock was the fifth biggest gainer in 'A' group. On the BSE, 2.71 lakh shares were traded on the counter so far as against the average daily volumes of 1.26 lakh shares in the past one month. Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
FDC schedules AGM

FDC announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
FDC to hold AGM

FDC announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
FDC consolidated net profit rises 8.33% in the June 2024 quarter

Net profit of FDC rose 8.33% to Rs 119.04 crore in the quarter ended June 2024 as against Rs 109.89 crore during the previous quarter ended June 2023. Sales rose 19.00% to Rs 638.27 crore in the quarter ended June 2024 as against Rs 536.38 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales638.27536.38 19 OPM %22.9722.75 - PBDT173.76150.37 16 PBT162.73140.74 16 NP119.04109.89 8 Powered by Capital Market - Live

2 months agoCapital Market - Live

Technical Breakout Stocks: How to trade FDC, Bandhan Bank and Tata Motors on Tuesday? - Market Summary

2 months agoEconomic Times

Volumes spurt at FDC Ltd counter

2 months agoBusiness Standard
Corporate
FDC to announce Quarterly Result

FDC will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live

Pharma shares shine; Dr Reddy’s, FDC, Glenmark, Suven trade at record highs

3 months agoBusiness Standard

Govt bans anti-cold drug combination for kids aged under four

9 months agoBusiness Today

Drug regulator issues warning against cold medication for children under 4 yrs

9 months agoMoneycontrol